| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.03 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.03 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.04 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |